Table 3.
FAS -670 A>G | Treatment status (n=93) | ||||
---|---|---|---|---|---|
Resistance (n=46) | Response (n=47) | P value | Adjusted OR (95% CI) | P value | |
Genotype | |||||
AA | 8 (17.4%) | 5 (10.6%) | 0.348 | 1 (Reference) | |
AG | 22 (47.8%) | 32 (68.1%) | 0.048* | 0.429 (0.124-1.488) | 0.43 |
GG | 16 (34.8%) | 10 (21.3%) | 0.147 | 1.000 (0.255-3.929) | 1 |
Allele | |||||
A | 38 (41.3%) | 42 (44.7%) | 1 (Reference) | ||
G | 54 (58.7%) | 52 (55.3%) | 0.639 | 1.148 (0.642-2.052) | 0.639 |
FASL-844 T>C | Treatment status (n=90) | ||||
Resistance (n=45) | Response (n=45) | P value | Adjusted OR (95% CI) | P value | |
Genotype | |||||
TT | 17 (37.8%) | 5 (11.1%) | 0.003* | 1 (Reference) | - |
TC | 7 (15.5%) | 16 (35.6%) | 0.029* | 0.129 (0.034-0.489) | 0.003* |
CC | 21 (46.7%) | 24 (53.3%) | 0.527 | 0.257 (0.081-0.818) | 0.021* |
Allele | |||||
T | 41 (45.6%) | 26 (28.9%) | 1 (Reference) | ||
C | 49 (54.4%) | 64 (71.1%) | 0.002* | 0.486 (0.262-0.899) | 0.021* |
*p<0.05 statistically significant; OR, odd ratio; CI, confidence interval